focus -WSS

focus

author：fashion 2025-08-25 07:25:47 - browse：9

A colorful illustrated montage of money, people in suits, and pills – business, politics and policy coverage from STAT — Mike Reddy for STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletterfollowing the flow of money in medicine. Sign upto get it in your inbox every Monday.

We did something a little different for this issue: We wanted to share some of the stories that explain the machinations of the U.S. health care system — stories that really influenced how we think about and report on this industry. Drop us a line to let us know which stories have resonated with you over the years: [email protected] and [email protected].

‘It’s The Prices, Stupid’

Everyone’s first major encounter with the health care system usually results in surprise and confusion. Whether it’s childbirth, caring for a family member, or dealing with one’s own injury or illness, a bill inevitably comes in the mail leaving most people asking, “Why does everything cost so much?” The answer invariably comes back to a popular 2003 journal article from a quartet of health economists titled, “It’s The Prices, Stupid.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Supreme Court mifepristone arguments center on docs' right to sue

knowledge

focus

WSS

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Merck drug for rare lung condition set for approval in U.S.

Vertex Pharmaceuticals may move headquarters in Boston

Police still searching for prisoner who escaped from NYC hospital

American woman, child freed after being kidnapped in Haiti last month

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

hotspot

focus

‘It’s The Prices, Stupid’

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

How to save PrEP access — and even expand it

In same hospitals, Black patients receive fewer opioids than white patients

Peter Hotez and the public health issue of online harassment

Anavex keeps shifting the goalposts in its clinical trials

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Supreme Court mifepristone arguments center on docs' right to sue

ChatGPT in medicine: STAT answers readers' burning questions

Anavex keeps shifting the goalposts in its clinical trials

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

knowledge

Readout Newsletter: Merck, Vertex, and Viking updates

Study says nonprofit hospitals fall short in charity care spending

Patient advocates debate FDA's accelerated approval process

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

FDA's naming rule on biosimilars has undermined competition

knowledge

knowledge

focus

explore